Title : Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo.

Pub. Date : 2014 Nov

PMID : 25313624






10 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Fibroblast growth factor 21 (FGF-21), which is a modulator of glucose and lipid homeostasis, acts as a novel therapeutic reagent for many metabolic perturbations. Glucose fibroblast growth factor 21 Rattus norvegicus
2 Fibroblast growth factor 21 (FGF-21), which is a modulator of glucose and lipid homeostasis, acts as a novel therapeutic reagent for many metabolic perturbations. Glucose fibroblast growth factor 21 Rattus norvegicus
3 The results indicated that FGF-21 significantly enhanced cell viability and decreased the degree of DNA fragmentation in HUVECs, as caused by H2O2 stress induction. Hydrogen Peroxide fibroblast growth factor 21 Rattus norvegicus
4 Further studies revealed that FGF-21 inhibited H2O2-induced cell apoptosis by preventing the activation of mitogen-activated protein kinase (MAPK) signaling pathways. Hydrogen Peroxide fibroblast growth factor 21 Rattus norvegicus
5 In an established rat model, FGF-21 dramatically improved the condition of atherosclerotic rats by decreasing serum levels of total triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and total cholesterol (TC), and by increasing the serum levels of high density lipoprotein cholesterol (HDL-C). Triglycerides fibroblast growth factor 21 Rattus norvegicus
6 In an established rat model, FGF-21 dramatically improved the condition of atherosclerotic rats by decreasing serum levels of total triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and total cholesterol (TC), and by increasing the serum levels of high density lipoprotein cholesterol (HDL-C). Triglycerides fibroblast growth factor 21 Rattus norvegicus
7 In an established rat model, FGF-21 dramatically improved the condition of atherosclerotic rats by decreasing serum levels of total triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and total cholesterol (TC), and by increasing the serum levels of high density lipoprotein cholesterol (HDL-C). Cholesterol fibroblast growth factor 21 Rattus norvegicus
8 In an established rat model, FGF-21 dramatically improved the condition of atherosclerotic rats by decreasing serum levels of total triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and total cholesterol (TC), and by increasing the serum levels of high density lipoprotein cholesterol (HDL-C). Technetium fibroblast growth factor 21 Rattus norvegicus
9 FGF-21 also has antioxidant effects in the atherosclerotic rat, such that increased levels of superoxide dismutase, reduced glutathione, and reduced malondialdehyde were observed. Glutathione fibroblast growth factor 21 Rattus norvegicus
10 FGF-21 also has antioxidant effects in the atherosclerotic rat, such that increased levels of superoxide dismutase, reduced glutathione, and reduced malondialdehyde were observed. Malondialdehyde fibroblast growth factor 21 Rattus norvegicus